251 related articles for article (PubMed ID: 21301783)
1. Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial.
Spiel AO; Bartko J; Schwameis M; Firbas C; Siller-Matula J; Schuetz M; Weigl M; Jilma B
Thromb Haemost; 2011 Apr; 105(4):655-62. PubMed ID: 21301783
[TBL] [Abstract][Full Text] [Related]
2. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
[TBL] [Abstract][Full Text] [Related]
3. Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans.
Spiel AO; Siller-Matula J; Firbas C; Leitner JM; Russmueller G; Jilma B
Platelets; 2010; 21(6):464-9. PubMed ID: 20528259
[TBL] [Abstract][Full Text] [Related]
4. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets.
Shimoda K; Okamura S; Harada N; Kondo S; Okamura T; Niho Y
J Clin Invest; 1993 Apr; 91(4):1310-3. PubMed ID: 7682568
[TBL] [Abstract][Full Text] [Related]
5. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
[TBL] [Abstract][Full Text] [Related]
7. The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.
Yu KM; Inoue Y; Umeda M; Terasaki H; Chen ZY; Iwai T
Thromb Res; 2011 May; 127(5):418-25. PubMed ID: 21334044
[TBL] [Abstract][Full Text] [Related]
8. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
10. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
Karadogan C; Karadogan I; Bilgin AU; Undar L
Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
[TBL] [Abstract][Full Text] [Related]
11. Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry.
Panzer S; Höcker L; Koren D
Ann Hematol; 2006 Feb; 85(2):121-5. PubMed ID: 16283308
[TBL] [Abstract][Full Text] [Related]
12. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
LeBlanc R; Roy J; Demers C; Vu L; Cantin G
Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Xiao Z; Théroux P
J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401
[TBL] [Abstract][Full Text] [Related]
15. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia.
Yıldırım ZK; Orhan MF; Büyükavcı M
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745
[TBL] [Abstract][Full Text] [Related]
16. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
18. Whole blood platelet aggregation in humans and animals: a comparative study.
Soloviev MV; Okazaki Y; Harasaki H
J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
[TBL] [Abstract][Full Text] [Related]
19. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
Grigg A; Begley CG; Juttner CA; Szer J; To LB; Maher D; McGrath KM; Morstyn G; Fox RM; Sheridan WP
Bone Marrow Transplant; 1993; 11 Suppl 2():23-9. PubMed ID: 8334435
[TBL] [Abstract][Full Text] [Related]
20. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
